News Daily News Coronary CTA in the ED for Chest Pain Ups Statins, Aspirin on Discharge in Those at Highest Risk Yael L. Maxwell December 12, 2017
News Daily News Better Outcomes Seen for Stroke Patients Taken Directly to Thrombectomy Hospitals, but Protocols Lacking Yael L. Maxwell September 28, 2017
News Daily News Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease Yael L. Maxwell September 15, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Conference News SCCT 2017 Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking Yael L. Maxwell July 13, 2017
News Daily News Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing? Yael L. Maxwell July 12, 2017
News Conference News SCCT 2017 Image Quality vs Radiation Dose: A Tricky Balance for Cardiac CT Yael L. Maxwell July 11, 2017
News Conference News SCCT 2017 Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See? Yael L. Maxwell July 10, 2017
News Conference News SCCT 2017 Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration Yael L. Maxwell July 09, 2017
News Conference News SCCT 2017 Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions Yael L. Maxwell July 08, 2017
News Daily News ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation Yael L. Maxwell June 29, 2017
News Conference News EAS 2017 Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive Yael L. Maxwell May 01, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS Yael L. Maxwell March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017